[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0yWL5Atc5RvXVj72e2U2LoE5I_srZ83gEi7SuEwVt4Q":8,"$fIAJcAkSlvB5_VbudV3mAacYTVQDRI3N_NhR5xxMA0yc":55,"$fn7dTXy2rDtZUYFHA1F23qPV4qcraccq6Btamj7Ovu20":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},49290,867607,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//u4Kcsm8J23DFi9vsfDo509m3ezWIOgZe.png","戴振兴","盐城市第一人民医院","肿瘤科","主治医师",129,0,"宫颈癌术后肺转移用药方案实用指南","","https://ystcdn.venuertc.com/venue/AI/8679e72d-46b9-49c0-ba51-a54f53d3e03f.jpg","\u003Ch1 id=\"material_title\" class=\"cervical-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">宫颈癌术后肺转移用药方案实用指南\u003C/h1>\n\n\u003Cdiv class=\"cervical-drug-intro\">\n  \u003Cp>聊到宫颈癌术后肺转移的治疗，不少人第一时间想到“化疗”，其实这只是其中的一部分。如今，包括免疫调节、靶向药物在内的多种药品，已成为治疗的重要选择。每种药物的使用都有讲究，比如什么时候用、怎么配合、怎样降低副作用。本文着重介绍三类常用药品及其配套支持药物，帮你掌握\u003Cstrong>7个关键用药细节\u003C/strong>，用药安全稳稳的。\u003C/p>\n\u003C/div>\n\n\u003C!-- 1. 药品种类与作用机制概览 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要药品与作用机制\u003Cspan>🧬\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    宫颈癌术后肺转移的治疗常见药品包括以下几类：\u003Cbr>\n    \u003Cstrong>1）铂类药物\u003C/strong>（如卡铂）：这些药主要通过破坏细胞DNA，阻止肿瘤细胞复制。\u003Cbr>\n    \u003Cstrong>2）紫杉类药物\u003C/strong>（如白蛋白结合型紫杉醇）：作用于细胞分裂时的微管，使肿瘤细胞“卡壳”无法正常分裂。\u003Cbr>\n    \u003Cstrong>3）免疫检查点抑制剂\u003C/strong>：这类药物不是直接杀死肿瘤细胞，而是激活自身免疫细胞，让身体“识别并清除”异常的肿瘤细胞。\u003Cbr>\n    辅助用药如止吐药、护肝药和支持药物，旨在减轻治疗过程中的不适，提高整体耐受性。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-note\">正确做法：了解药物的主要机制有助于你配合治疗和应对可能的不良反应。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 2. 服用时间和方法 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品使用时机与服用方法\u003Cspan>⏰\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>1）化疗药物（如卡铂、白蛋白结合型紫杉醇）\u003C/strong>多为静脉注射，当天通常在专业机构完成。\u003Cbr>\n    \u003Cstrong>2）免疫检查点抑制剂\u003C/strong>按制定周期（如每三周一次）静脉滴注一次，单次用药需在有应急抢救条件的医院进行。\u003Cbr>\n    \u003Cstrong>3）辅助药物\u003C/strong>如止吐药（常见为口服或静脉）、保肝药（多为口服），均需遵医嘱，部分药物建议餐后服用以减少胃肠道反应。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-tip\">正确做法：任何药品使用和调整必须严格遵照专业医师和药师的指导，并知晓每次用药的具体间隔和持续时间。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 3. 剂型特点与实际操作技巧 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型选择与操作小贴士\u003Cspan>💊\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>1）注射用化疗药\u003C/strong>（如卡铂、紫杉醇）：需稀释后静脉滴注。化疗当天宜饮水充足，帮助药物代谢。\u003Cbr>\n    \u003Cstrong>2）白蛋白结合型紫杉醇\u003C/strong>比传统紫杉醇减轻了溶剂相关过敏，输液时间略短，但依然要留意过敏观察。\u003Cbr>\n    \u003Cstrong>3）辅助药（如口服止吐药）\u003C/strong>要用足够的水送服，不建议嚼服片剂。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-tip\">实际用药案例：有位中年女性患者在免疫联合化疗过程中，通过规范静脉输注和遵医嘱服用支持用药，有效减轻了恶心等不适。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 4. 药物相互作用安全提示 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 常见药物相互作用及规避方法\u003Cspan>⚠️\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>1）紫杉醇与卡铂可联用\u003C/strong>但与某些降压药、心脏药、抗生素等可能产生相互作用，可能增加毒性或影响代谢。\u003Cbr>\n    \u003Cstrong>2）免疫检查点抑制剂与激素药物\u003C/strong>同时使用时可能减弱免疫治疗效果，除非不可避免不建议合用。\u003Cbr>\n    \u003Cstrong>3）辅助用药（如止吐药）与心理类药品、部分镇静催眠药同用，需警惕中枢抑制风险。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-note\">特别提醒：服药期间新加药品或调整用法前，一定要提前告知医生和药师，避免隐形的药物相互作用带来风险。\u003C/span>\n  \u003C/strong>\u003C/p>\u003Cstrong>\n\u003C/strong>\u003C/section>\u003Cstrong>\n\n\u003C!-- 5. 用药剂量、给药频率与特殊人群调整 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药剂量与特殊人群注意事项\u003Cspan>👩‍⚕️\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>1）成年患者\u003C/strong>：如卡铂推荐剂量常按体表面积或肾功能公式计算，免疫药物通常有固定剂量（如200mg/次）。\u003Cbr>\n    \u003Cstrong>2）老年患者\u003C/strong>：常需监测肾肝功能，部分药物需减量。\u003Cbr>\n    \u003Cstrong>3）肝肾功能减弱者\u003C/strong>：需根据具体指标进行个体化调整。\u003Cbr>\n    \u003Cstrong>4）妊娠及哺乳期妇女\u003C/strong>：这些药品通常不建议用，如需特殊情况必须评估利弊。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-tip\">案例参考：一位60岁女性辅助化疗时出现轻微肾功能下降，经降低卡铂剂量后，安全完成了全部化疗方案。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 6. 常见不良反应、识别与应对 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 不良反应表现与处理措施\u003Cspan>🩺\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>化疗药物\u003C/strong>（卡铂、紫杉醇）：\u003Cbr>\n     1）\u003Cstrong>恶心、呕吐\u003C/strong>：辅以止吐药防治，出现频繁应随时就诊。\u003Cbr>\n     2）\u003Cstrong>骨髓抑制\u003C/strong>（感染、出血风险增高）：需定期检验血常规。\u003Cbr>\n     3）\u003Cstrong>脱发、口腔黏膜损伤\u003C/strong>：多为可逆，注意口腔卫生。\u003Cbr>\n    \u003Cstrong>免疫检查点抑制剂\u003C/strong>：\u003Cbr>\n     1）\u003Cstrong>免疫相关不良反应\u003C/strong>（如皮疹、乏力）：如出现持续发热、全身不适要及时报告医师。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-note\">正确做法：接受这些药品期间定期报告任何不适，配合医护团队尽早干预，提升治疗安全性。\u003C/span>\n    \u003Cbr>\n    \u003Cem>临床研究显示：免疫药物相关严重不良反应发生率约为10-20%\u003Cspan class=\"cervical-drug-quote\">（参考：Postow et al., 2015）\u003C/span>。\u003C/em>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 7. 药品的储存与用药遗忘处理 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存方式与漏服补救\u003Cspan>📦\u003C/span>\u003C/h2>\n  \u003C/div>\n  \u003Cp>\n    \u003Cstrong>化疗及免疫药品\u003C/strong>常为冷藏运输与保存，但专业机构会按规范操作。\u003Cbr>\n    \u003Cstrong>辅助口服药物\u003C/strong>，如止吐、保肝药，通常储存在25℃以下阴凉干燥处，避免阳光直射和潮湿环境。\u003Cbr>\n    \u003Cstrong>漏服口服药物\u003C/strong>：若临近下一次服药时间，则跳过漏服剂量，切勿一次补服两倍。遇到注射药品剂量偏差，第一时间联络专业人员处理。\u003Cbr>\n    \u003Cspan class=\"cervical-drug-note\">正确做法：用药期间可用闹钟、药盒等辅助工具记录时间，确保每次服药不错漏。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003C!-- 8. 结语（用药总结与温和提醒） -->\n\u003Cdiv class=\"cervical-drug-summary\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：用药细节决定疗效\u003C/h2>\n  \u003Cp>每一种用于宫颈癌术后肺转移的药品，无论是化疗、免疫还是支持用药，都有专属的用法、剂量和注意事项。牢记每一种药品的关键风险点、正确操作要求与组合搭配原则，是安全用药的核心。遇到不适或疑问时，及时联系专业医护团队，才能获得最好的治疗效果。\u003Cbr>\n  \u003Cspan class=\"cervical-drug-note\">最重要的两点：严格遵医嘱规范操作，警惕不良反应及时报告。\u003C/span>\u003Cbr>\n  合理用药，让每一份治疗变得更有把握、更安心。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 9. 参考文献 -->\n\u003Csection class=\"cervical-drug-section\">\n  \u003Cdiv class=\"cervical-drug-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n  \u003C/div>\n  \u003Col class=\"cervical-drug-ref-list\">\n    \u003Cli>\n      Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015). Immune Checkpoint Blockade in Cancer Therapy. \u003Cem>Journal of Clinical Oncology\u003C/em>, 33(17), 1974–1982. https://doi.org/10.1200/JCO.2014.59.6968\n    \u003C/li>\n    \u003Cli>\n      Markman, M. et al. (2001). Carboplatin dosing: Current practice and rationale in the era of novel targeting agents. \u003Cem>Journal of Clinical Oncology\u003C/em>, 19(9), 2920–2922.\n    \u003C/li>\n    \u003Cli>\n      Wang, S., et al. (2021). Management of adverse events associated with immune checkpoint inhibitors. \u003Cem>ESMO Open\u003C/em>, 6(3), 100107. https://doi.org/10.1016/j.esmoop.2021.100107\n    \u003C/li>\n    \u003Cli>\n      UpToDate. (2024). Overview of the management of gynecologic cancers.\n    \u003C/li>\n  \u003C/ol>\n\u003C/section>\n\n\u003Cstyle>\n.cervical-drug-title {\n  font-size: 2.2rem;\n  font-weight: bold;\n  text-align: center;\n  color: #31548e;\n  margin-top: 30px;\n  margin-bottom: 25px;\n  letter-spacing: 2px;\n}\n.cervical-drug-intro {\n  max-width: 780px;\n  margin: 0 auto 28px auto;\n  font-size: 1.12rem;\n  color: #2c2c2c;\n  background: #e7ecf5;\n  border-radius: 10px;\n  padding: 20px 29px 15px 29px;\n  box-shadow: 0 2px 8px rgba(85,108,155,0.08);\n}\n.cervical-drug-section {\n  max-width: 820px;\n  margin: 30px auto 0 auto;\n  font-size: 1.12rem;\n  color: #22315a;\n  line-height: 1.88;\n}\n.cervical-drug-bg {\n  background: linear-gradient(90deg, #e3eaf6 30%, #f8fafc 100%);\n  padding: 13px 0 8px 38px;\n  margin-bottom: 14px;\n  border-radius: 6px;\n  box-shadow: 0 1px 4px rgba(160,180,219,0.05);\n}\n.cervical-drug-section h2 {\n  font-size: 1.33rem;\n  color: #1b346b;\n  font-weight: bold;\n  display: inline-block;\n  letter-spacing: 1.2px;\n  margin: 0;\n}\n.cervical-drug-tip {\n  display: inline-block;\n  background: #eafeef;\n  color: #019875;\n  border-radius: 4px;\n  padding: 3px 8px;\n  font-size: 1em;\n  margin-top: 5px;\n  margin-right: 5px;\n  font-weight: 600;\n}\n.cervical-drug-note {\n  display: inline-block;\n  background: #f7f2e8;\n  color: #be9836;\n  border-radius: 4px;\n  padding: 3px 8px;\n  font-size: 1em;\n  margin-top: 5px;\n  font-weight: 600;\n}\n.cervical-drug-section em {\n  color: #5270B3;\n  font-style: italic;\n}\n.cervical-drug-quote {\n  color: #858fb2;\n  background: #f1f3fa;\n  border-radius: 3px;\n  padding: 0 4px;\n  font-size: 90%;\n}\n.cervical-drug-summary {\n  max-width: 840px;\n  margin: 37px auto 0 auto;\n  background: #eff7fb;\n  border-radius: 12px;\n  box-shadow: 0 2px 10px rgba(60,90,170,0.06);\n  padding: 22px 35px 20px 35px;\n}\n.cervical-drug-summary h2 {\n  color: #2565af;\n  font-size: 1.20rem;\n  margin-bottom: 7px;\n  margin-top: 0;\n  font-weight: bold;\n}\n.cervical-drug-summary p {\n  color: #1d385c;\n  font-size: 1.09rem;\n  line-height: 1.95;\n}\n.cervical-drug-ref-list {\n  padding-left: 30px;\n  color: #535e8e;\n  line-height: 1.69;\n  font-size: 1em;\n  margin: 14px 0 30px 0;\n}\n@media (max-width: 900px){\n  .cervical-drug-intro, .cervical-drug-section, .cervical-drug-summary {padding-left:10px;padding-right:10px;}\n  .cervical-drug-title {font-size:1.4rem;}\n}\n\u003C/style>\n\u003C/strong>","\u003Ch1 id=\"material_title\" class=\"cervical-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px",507,"2025-07-16 09:41:16","宫颈癌, 肺转移, 化疗, 免疫治疗, 用药指南, 剂量调整, 不良反应, 用药管理","这篇指南深入解析宫颈癌术后肺转移的多种治疗药物，包括化疗、免疫检查点抑制剂等，帮助患者了解用药安全与效果，提高治疗信心和安全性。","2025-07-19 16:58:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]